Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan

被引:37
|
作者
Khan, Imran [1 ]
Ahmad, Nafees [1 ]
Khan, Shereen [2 ]
Muhammad, Shafi [3 ]
Khan, Shabir Ahmad [4 ]
Ahmad, Izaz [5 ]
Khan, Asad [1 ]
Gulalai [1 ]
Atif, Muhammad [6 ]
机构
[1] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Pakistan
[2] Bolan Med Coll Quetta, Quetta, Pakistan
[3] Univ Baluchistan Quetta, Fac Pharm & Hlth Sci, Dept Pharmacognosy, Quetta, Pakistan
[4] Univ Baluchistan Quetta, Ctr Excellence Vaccinol & Biotechnol, Quetta, Pakistan
[5] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[6] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Pakistan
关键词
Baluchistan; Body weight; Death; MDR-TB; Ofloxacin; RISK-FACTORS; PROGRAMMATIC MANAGEMENT; LATENT TUBERCULOSIS; RATES; PREVALENCE; PREDICTORS; DEATH;
D O I
10.1016/j.jiph.2019.04.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Evaluating treatment outcomes of a cohort of patients is an effective way for analyzing the effectiveness of a program. Information regarding drug resistance pattern, detailed management, treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant (MDR-TB) patients is missing from Baluchistan province of Pakistan. Methods This study was carried out at Programmatic Management of Drug Resistant TB unit at Fatimah Jinnah General and Chest Hospital Quetta. All eligible 186 MDR-TB patients enrolled at the study site from January 1, 2012 to April 30, 2016 were retrospectively followed until the treatment outcomes were reported. Data was abstracted through a standardized data collection form and analysed by SPSS 20. Multivariate binary logistic regression (MVBLR) analysis was used to evaluate factors associated with i) death and treatment failure and ii) lost to follow up. A p-value of <0.05 was considered statistically significant. Results The study participants were resistant to a median of four drugs (range 28) with majority being resistant to any second-line anti-TB drug (SLD) (55.5%). Among SLD, resistance was highest for ofloxacin (52.2%). The study site had an overall treatment success rate of 71.6%. A total of 129 (69.4%) patients were cured, four (2.2%) completed treatment, 37 died (19.9%), 14 (7.5%) were lost to follow up and two (1.1%) were declared treatment failures. In MVBLR analysis, patients age of >40 years (OR?=?4.249, p-value?=?0.001) had statistically significant positive and baseline body weight of >40?kg (OR?=?0.256, p-value?=?0.002) had statistically significant negative association with death and treatment failure. No factor had statistical significant association with lost to follow up. Conclusion Overall treatment success rate was promising but did not achieve the target success rate (>75%) set by World Health Organization. It can be further improved by paying special attention and providing enhanced management to the patients with risk factors for unsuccessful outcomes. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgg/licensesiby-nc-nd/4.0/).
引用
收藏
页码:809 / 815
页数:7
相关论文
共 50 条
  • [31] Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa
    Marais, E.
    Mlambo, C. K.
    Lewis, J. J.
    Rastogi, N.
    Zozio, T.
    Grobusch, M. P.
    Duse, A.
    Victor, T.
    Warren, R. W.
    INFECTION, 2014, 42 (02) : 405 - 413
  • [32] Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa
    E. Marais
    C. K. Mlambo
    J. J. Lewis
    N. Rastogi
    T. Zozio
    M. P. Grobusch
    A. Duse
    T. Victor
    R. W. Warren
    Infection, 2014, 42 : 405 - 413
  • [33] Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis
    Chien, Jung-Yien
    Chien, Shun-Tien
    Chiu, Wei-Yih
    Yu, Chong-Jen
    Hsueh, Po-Ren
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4708 - 4716
  • [34] PREDICTORS OF TREATMENT OUTCOMES AMONG MULTIDRUG RESISTANT TUBERCULOSIS IN TANZANIA
    Leveri, T.
    Lekule, I
    Mollel, E.
    Lyamuya, F.
    Kalonzo, K.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S266 - S266
  • [35] Treatment Outcomes in Multidrug-Resistant Tuberculosis During Pregnancy
    Liu, Xuhui
    Xia, Lu
    Wang, Xiaomin
    Huang, Zhen
    Lu, Shuihua
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 1073 - 1073
  • [36] Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan
    Lin, Chih-Bin
    Sun, Hung-Chieh
    Chiang, Chen-Yuan
    Wu, Che-Wei
    Chou, Hsu-Wen
    Tang, Tao-Qian
    Lee, Jen-Jyh
    TZU CHI MEDICAL JOURNAL, 2019, 31 (01): : 35 - 39
  • [37] Treatment Outcomes Of Multidrug-Resistant Tuberculosis In The Era Of Linezolid
    Kwak, N.
    Choi, S.
    Lee, J.
    Park, Y.
    Lee, C.
    Lee, S. -M.
    Yoo, C. -G.
    Kim, Y.
    Han, S.
    Yim, J. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [38] More on Treatment Outcomes in Multidrug-Resistant Tuberculosis Reply
    Lange, Christoph
    Guenther, Gunar
    van Leth, Frank
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26): : 2611 - 2611
  • [39] Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi?an China, a Retrospective Cohort Study
    Ma, Jin-Bao
    Zeng, Ling-Cheng
    Ren, Fei
    Dang, Li-Yun
    Luo, Hui
    Wu, Yan-Qin
    Yang, Xin-Jun
    Li, Rong
    Yang, Han
    Xu, You
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4947 - 4957
  • [40] Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China
    Zhang, Ming-Wu
    Zhou, Lin
    Zhang, Yu
    Chen, Bin
    Peng, Ying
    Wang, Fei
    Liu, Zheng-Wei
    Wang, Xiao-Meng
    Chen, Song-Hua
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)